FF: First generation of revenue, narrowing of operating losses in the third quarter
123458026
发表于 2023-11-14 12:22:56
1309
0
0
Faraday Future (FF), a subsidiary of Jia Yueting, announced its third quarter financial report on the 14th. It generated revenue for the first time, with sales costs of $16.1 million and an operating loss of $66.4 million, compared to a loss of $80 million in the same period last year. FF stated that the narrowing of operating losses is mainly due to a decrease in research and development expenses, followed by an improvement in management expenses. Currently, FF has delivered 7 FF 91 vehicles to new users. According to the plan, FF's goal for next year is to achieve production of approximately 1000 cars, provided that it can obtain the required capital, supply chain capacity and stability, and obtain necessary permits.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
You may like
- Huize Insurance's customer base exceeds 10 million, contributing to a total premium of 2.06 billion yuan in the third quarter of 2024
- BOSS direct recruitment: Q3 revenue of 1.912 billion yuan, a year-on-year increase of 19%
- BOSS direct recruitment: Q3 revenue of 1.912 billion yuan, a year-on-year increase of 19%
- BOSS directly hired third quarter revenue of 1.912 billion yuan, a year-on-year increase of 19%
- Education Technology: Net loss of 129 million yuan in the first three quarters of this year, plans to repurchase 10 million US dollars of common stock within one year
- 51Talk's revenue in the first three quarters of this year increased by 75% year-on-year, while its losses decreased by 39.6% year-on-year
- BeiGene ADC's new cancer drug BG-C137 has been clinically approved for the first time in China
- Hong En's average monthly active users hit a new high in the third quarter of 2024
- Blue Origin New Glenn rocket launches critical tests before first launch
- Beike acquires land for the first time in Shanghai to build a building. This year, the final battle of homestead transactions has ignited new highlights